PTHETF / FundInvesco Dorsey Wright Healthcare Momentum ETF
Verdicts genuinely change. Free email alert the moment PTH's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Invesco Dorsey Wright Healthcare Momentum ETF ETF · Invesco Exchange-Traded Fund Trust
57 holdings · as of 2026-07-31 (3.4 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 128% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT At least 19.52% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 63% turns out to be. Matching more holdings can only raise this share, never lower it.
57 holdings, 35 matched (50% of weight). Portfolio as of 2026-07-31, filed 2026-09-28. Source: SEC Form N-PORT.
3.01% of this portfolio’s income is non-permissible — weighted across holdings, computed over 46% of portfolio weight (31 of 57 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
All holdings (57)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| Invesco Private Prime Fund | UNSCREENED | 20.79% | no in-house ratios for this holding |
| Invesco Private Government Fund | UNSCREENED | 6.83% | no in-house ratios for this holding |
| GH Guardant Health, Inc. | COMPLIANT | 4.97% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| Roivant Sciences Ltd. | UNSCREENED | 4.95% | no in-house ratios for this holding |
| Revolution Medicines, Inc. | UNSCREENED | 4.94% | no in-house ratios for this holding |
| AXSM Axsome Therapeutics, Inc. | COMPLIANT | 4.12% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| BTSG BrightSpring Health Services, Inc. | COMPLIANT | 4.03% | AAOIFI20.1% Usmani39.9% Dow Jones Islamic35.2% S&P Shariah43.5% MSCI Islamic39.6% MSCI Islamic M-Series43.5% FTSE Shariah36.6% |
| LQDA Liquidia Corp. | COMPLIANT | 3.01% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| Erasca, Inc. | UNSCREENED | 2.94% | no in-house ratios for this holding |
| Oruka Therapeutics, Inc. | UNSCREENED | 2.74% | no in-house ratios for this holding |
| TXG 10x Genomics, Inc. | COMPLIANT | 2.27% | AAOIFI1.0% Usmani7.6% Dow Jones Islamic3.2% S&P Shariah2.5% MSCI Islamic7.6% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| Relay Therapeutics, Inc. | UNSCREENED | 2.25% | no in-house ratios for this holding |
| TNGX Tango Therapeutics Inc. | NON_COMPLIANT | 2.16% | AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic3.0% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| TVTX Travere Therapeutics, Inc. | COMPLIANT | 2.16% | AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4% |
| OSCR Oscar Health, Inc. | NON_COMPLIANT | 2.10% | AAOIFI4.3% Usmani3.8% Dow Jones Islamic8.0% S&P Shariah8.8% MSCI Islamic3.8% MSCI Islamic M-Series8.8% FTSE Shariah3.8% |
| ILMN Illumina, Inc. | COMPLIANT | 2.08% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| agilon health, Inc. | UNSCREENED | 2.07% | no in-house ratios for this holding |
| AXGN Axogen, Inc. | COMPLIANT | 2.06% | AAOIFI0.8% Usmani6.6% Dow Jones Islamic1.7% S&P Shariah2.2% MSCI Islamic6.6% MSCI Islamic M-Series2.2% FTSE Shariah0.0% |
| ARWR Arrowhead Pharmaceuticals, Inc. | COMPLIANT | 2.01% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Spyre Therapeutics, Inc. | UNSCREENED | 2.01% | no in-house ratios for this holding |
| Replimune Group, Inc. | UNSCREENED | 1.93% | no in-house ratios for this holding |
| JAZZ Jazz Pharmaceuticals PLC | NON_COMPLIANT | 1.93% | AAOIFI38.6% Usmani46.9% Dow Jones Islamic55.2% S&P Shariah61.2% MSCI Islamic46.9% MSCI Islamic M-Series61.2% FTSE Shariah46.4% |
| MRNA Moderna, Inc. | NON_COMPLIANT | 1.90% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| CYTK Cytokinetics, Inc. | NON_COMPLIANT | 1.89% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| VTRS Viatris Inc. | NON_COMPLIANT | 1.82% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| CNC Centene Corp. | NON_COMPLIANT | 1.79% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| HUM Humana Inc. | NON_COMPLIANT | 1.77% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| LGND Ligand Pharmaceuticals Inc. | COMPLIANT | 1.74% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| CORT Corcept Therapeutics Inc. | COMPLIANT | 1.71% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Enliven Therapeutics, Inc. | UNSCREENED | 1.70% | no in-house ratios for this holding |
| TWST Twist Bioscience Corp. | COMPLIANT | 1.59% | AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| HIMS Hims & Hers Health, Inc. | COMPLIANT | 1.57% | AAOIFI2.8% Usmani5.0% Dow Jones Islamic2.2% S&P Shariah2.9% MSCI Islamic5.0% MSCI Islamic M-Series2.9% FTSE Shariah0.0% |
| MBX Biosciences, Inc. | UNSCREENED | 1.53% | no in-house ratios for this holding |
| ARQT Arcutis Biotherapeutics, Inc. | COMPLIANT | 1.53% | AAOIFI3.8% Usmani23.4% Dow Jones Islamic5.0% S&P Shariah6.5% MSCI Islamic23.4% MSCI Islamic M-Series6.5% FTSE Shariah22.3% |
| ESTA Establishment Labs Holdings Inc. | COMPLIANT | 1.51% | AAOIFI12.0% Usmani75.4% Dow Jones Islamic17.1% S&P Shariah18.8% MSCI Islamic75.4% MSCI Islamic M-Series18.8% FTSE Shariah74.4% |
| uniQure N.V. | UNSCREENED | 1.50% | no in-house ratios for this holding |
| PACS PACS Group, Inc. | NON_COMPLIANT | 1.33% | AAOIFI47.0% Usmani60.2% Dow Jones Islamic83.6% S&P Shariahfail MSCI Islamic57.5% MSCI Islamic M-Seriesfail FTSE Shariah4.4% |
| EXEL Exelixis, Inc. | COMPLIANT | 1.31% | AAOIFI1.2% Usmani6.7% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic6.7% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| Trevi Therapeutics, Inc. | UNSCREENED | 1.17% | no in-house ratios for this holding |
| KRYS Krystal Biotech, Inc. | NON_COMPLIANT | 1.17% | AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| NHC National HealthCare Corp. | COMPLIANT | 1.12% | AAOIFI0.9% Usmani2.0% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic2.0% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| Amneal Pharmaceuticals, Inc. | UNSCREENED | 1.12% | no in-house ratios for this holding |
| ALKS Alkermes PLC | COMPLIANT | 1.10% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VCYT Veracyte, Inc. | COMPLIANT | 1.09% | AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| NEO NeoGenomics, Inc. | COMPLIANT | 1.08% | AAOIFI20.4% Usmani32.6% Dow Jones Islamic29.8% S&P Shariah26.9% MSCI Islamic32.2% MSCI Islamic M-Series26.9% FTSE Shariah27.2% |
| NUVB Nuvation Bio Inc. | NON_COMPLIANT | 1.06% | AAOIFI10.5% Usmani33.9% Dow Jones Islamic18.7% S&P Shariah23.6% MSCI Islamic33.9% MSCI Islamic M-Series23.6% FTSE Shariah33.4% |
| TGTX TG Therapeutics, Inc. | COMPLIANT | 1.06% | AAOIFI8.8% Usmani46.0% Dow Jones Islamic13.7% S&P Shariah17.0% MSCI Islamic46.0% MSCI Islamic M-Series17.0% FTSE Shariah45.5% |
| ABSI AbSci Corp. | COMPLIANT | 0.99% | AAOIFI— Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| Denali Therapeutics Inc. | UNSCREENED | 0.97% | no in-house ratios for this holding |
| Disc Medicine, Inc. | UNSCREENED | 0.89% | no in-house ratios for this holding |
| AMN Healthcare Services, Inc. | UNSCREENED | 0.82% | no in-house ratios for this holding |
| GRDN Guardian Pharmacy Services, Inc. | COMPLIANT | 0.80% | AAOIFI2.5% Usmani14.4% Dow Jones Islamic3.6% S&P Shariahpass MSCI Islamic14.4% MSCI Islamic M-Seriespass FTSE Shariah6.5% |
| Astrana Health, Inc. | UNSCREENED | 0.73% | no in-house ratios for this holding |
| Clover Health Investments, Corp. | UNSCREENED | 0.72% | no in-house ratios for this holding |
| Zevra Therapeutics, Inc. | UNSCREENED | 0.64% | no in-house ratios for this holding |
| NVCR NovoCure Ltd. | NON_COMPLIANT | 0.62% | AAOIFI13.9% Usmani29.2% Dow Jones Islamic12.6% S&P Shariah12.9% MSCI Islamic29.2% MSCI Islamic M-Series12.9% FTSE Shariah24.5% |
| Invesco Government & Agency Portfolio | UNSCREENED | 0.07% | no in-house ratios for this holding |
The published standards disagree about this fund by 29 points of portfolio weight — 35.5% of it passes AAOIFI, 6.4% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 35.5% ratios fail on 13.7% 78.6% not rated under AAOIFI
ratios pass on 11.8% ratios fail on 32.4% 83.5% not rated under Usmani
ratios pass on 27.4% ratios fail on 20.8% 79.5% not rated under Dow Jones Islamic
ratios pass on 27.4% ratios fail on 19.8% 80.5% not rated under S&P Shariah
ratios pass on 6.4% ratios fail on 39.3% 82.0% not rated under MSCI Islamic
ratios pass on 27.4% ratios fail on 20.8% 79.5% not rated under MSCI Islamic M-Series
ratios pass on 11.3% ratios fail on 32.9% 83.5% not rated under FTSE Shariah
35 of 57 listed holdings carry our own per-methodology verdicts (64% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 31 (59% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| TNGX Tango Therapeutics Inc. | 2.16% |
| OSCR Oscar Health, Inc. | 2.10% |
| JAZZ Jazz Pharmaceuticals PLC | 1.93% |
| MRNA Moderna, Inc. | 1.90% |
| CYTK Cytokinetics, Inc. | 1.89% |
| VTRS Viatris Inc. | 1.82% |
| CNC Centene Corp. | 1.79% |
| HUM Humana Inc. | 1.77% |
| PACS PACS Group, Inc. | 1.33% |
| KRYS Krystal Biotech, Inc. | 1.17% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Invesco Dorsey Wright Healthcare Momentum ETF (PTH) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for PTH — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 46.60 | NEUTRAL |
| Stochastic %K (14) | 34.72 | NEUTRAL |
| CCI (20) | -46.66 | NEUTRAL |
| Williams %R (14) | -65.28 | NEUTRAL |
| MACD (12,26,9) | 0.02 | BUY |
| ROC (10) | -5.34 | SELL |
| Momentum (10) | -3.27 | SELL |
| EMA (10) | 58.88 | SELL |
| SMA (10) | 58.73 | SELL |
| EMA (20) | 59.00 | SELL |
| SMA (20) | 58.91 | SELL |
| EMA (30) | 59.16 | SELL |
| SMA (30) | 58.77 | SELL |
| EMA (50) | 59.30 | SELL |
| SMA (50) | 59.76 | SELL |
| EMA (100) | 58.51 | SELL |
| SMA (100) | 59.91 | SELL |
| EMA (200) | 55.36 | BUY |
| SMA (200) | 55.00 | BUY |
About Invesco Dorsey Wright Healthcare Momentum ETF
The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics. Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in the components of the underlying index and in derivatives and other investments that have economic characteristics similar to the components of the underlying index.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 44 |
| 🕐 1H | RANGING | 53 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-03 · Asset managers net 928584 (+5135)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.